Silicon Genetics
https://www.agilent.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Silicon Genetics
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Masimo Acquires Lidco For $40.3M In Cash, Adds Complementary Hemodynamic Monitoring Tech
Masimo’s planned buyout of Lidco could help expand its footprint into the US.
Merck KGaA Finds The Right Home For Disease-Modifying OA Agent In Novartis
Novartis has added an anti-osteoarthritic Nanobody, M6495, to its growing pipeline of candidates for the condition, in a €450m agreement with Merck KGaA that sees the latter deliver on its plans to find new homes for its osteoarthritis pipeline.
Baxter Reports $45M Boost From COVID-19 Demand In Q1
The COVID-19 pandemic has increased demand for products from all of Baxter’s businesses except its advanced surgery division. Overall, the diversified company’s global sales were up 8% in the first quarter.
Company Information
- Other Names / Subsidiaries
-
- Agilent Technologies Inc.